Item 7.01 Regulation FD Disclosure
On November 14, 2022, Insulet Corporation (the “Company”) issued a press release
announcing a voluntary Medical Device Correction notice for its Omnipod® 5
Automated Insulin Delivery System due to an issue with the Omnipod 5 Controller
charging port and cable.
This voluntary Medical Device Correction notice does not impact the Omnipod 5
Pod, the Omnipod® DASH Insulin Management System, the Omnipod® Insulin
Management System, or compatible Android smartphone devices that have the
Omnipod 5 App installed.
A copy of the press release is attached as exhibit 99.1 to this Form 8-K.
The information in this Current Report on Form 8-K shall not be deemed “filed”
for purposes of Section 18 of the Securities Exchange Act of 1934, as amended,
or otherwise subject to liability of that section. The information in this
Current Report shall not be incorporated by reference into any filing or other
document pursuant to the Securities Act of 1933, as amended, except as shall be
expressly set forth by specific reference in such filing or document.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits. Exhibit No. Description 99.1 Press release dated November 14, 2022 104 Cover Page Interactive Date File (formatted as Inline XBRL)
© Edgar Online, source Glimpses